Skip to main content
. Author manuscript; available in PMC: 2015 Jul 28.
Published in final edited form as: J Cancer Ther. 2011 Mar 31;2(1):22–39. doi: 10.4236/jct.2011.21004

Figure 7.

Figure 7

Influence of increasing selenium concentrations on the cytotoxic anti-neoplastic potency of epirubicin (10−8 M) measured as a function of chemotherapeutic-resistant SKBr-3 mammary carcinoma cell vitality. Legend: (∎) selenium (methylseleninate); and (◆) selenium (methylseleni-nate) in combination with epirubicin (10−8 M). SKBr-3 monolayers were incubated with immunochemotherapeutics over a 72-hour period and cytotoxicity measured as a function of MTT cell vitality relative to matched negative reference controls.